https://lnkd.in/gHYap-sR Article title: COVID-19, nursing publication and the future of nursing research infection Author(s): Salam Banihani* Journal: Journal of Vaccines and Immunology Journal ISSN: 2640-7590 Abstract: Despite the advance in health sciences, the more frequent emerging of infectious diseases in recent decades raise due to environmental changes such as human activity, poor health care system, microbial adaptation, and substantial international movement [1]. This virus has a high mutation ratio with a substantial spread among the population through droplets, airborne, and contact as modes of transmission [2]. Generally, the Coronavirus affected our way of life and specifically the way of carrying out the research. It has significantly affected clinical research trials. Translational research that has the main role in moving the scientific findings into practice health care provision [3] must take place in improving the collaboration between research centers and hospitals where patients were recruited and finding ways to bridge the gap in funding projects. During the outbreak, many innovative technologies emerged such as virtual meetings in the health care systems and telehealth including telenursing technology which is considered as a cornerstone of health care in recent decades [4]. It is crucial to take the benefits of this technology in the research field, and cooperate at the national and international level to advance research in all aspects including efficacy, recruitment of participants, results, and dissemination of findings [5]. #COVID-19 #Nursing #Infection #ImmunologyMechanisms #AnimalModelsForImmunologicDiseases #ViralImmunology #Peertechz #Immunopathogenesis #VaccineDevelopmentAndEfficacyEvaluation #ImmuneResponsesToVaccines #VaccineTechnology #VaccineVectors #AdjuvantsAndImmunomodulators #ProphylacticVaccines #TherapeuticVaccines #AIDSVaccines #GeneVaccines #VaccinesInBioterrorism #RegulatoryAffairs #CommercialUtilization #Policy #Safety #Epidemiology #AntigenProcessingAndPresentation #DesignProductionAndDevelopmentOfVaccines #VaccineVectors #CellularAndMolecularImmuneResponses #BreakthroughsInImmunotherapeutics #VaccineSafety #PeertechzPublications #EfficacyAndClinicalTrials #ImmunityToInfection #Immunomodulation #CaseReports #ClassicalImmunology #ClinicalImmunology #ComputationalImmunology #DiagnosticImmunology #EvolutionaryImmunology #Immunotherapy #SystemsImmunology #CancerImmunology #TesticularImmunology
Health and Disease Prevention Group Journals’ Post
More Relevant Posts
-
https://lnkd.in/gxjTKK-W Article title: Prestigious Journals, Predatory Publishers and the Tall Poppy Syndrome in Medicine Author(s): Douglas E Garland* Journal: Journal of Vaccines and Immunology Journal ISSN: 2640-7590 Abstract: Fringe medicine (euphemistically called alternative), their articles (sometimes called throw aways) and products (supplements) have peacefully but uncomfortably coexisted with traditional medicine. The advent of the internet and the spread of misinformation have made traditional medicine evaluate its approach on all medical information. Traditional or prestigious journals, not without their own failings, are now in competition with the internet which includes open access e-journals, which have given rise to predatory publishers, as well as medical misinformation. Doctors must determine which articles are trustworthy. A new hybrid article may emerge. #PrestigiousJournals #OpenAccessJournals #PredatoryPublishers #TallPoppySyndrome #MedicalMisinformation #ImmunologyMechanisms #AnimalModelsForImmunologicDiseases #ViralImmunology #Peertechz #Immunopathogenesis #VaccineDevelopmentAndEfficacyEvaluation #ImmuneResponsesToVaccines #VaccineTechnology #VaccineVectors #AdjuvantsAndImmunomodulators #ProphylacticVaccines #TherapeuticVaccines #AIDSVaccines #GeneVaccines #VaccinesInBioterrorism #RegulatoryAffairs #CommercialUtilization #Policy #Safety #Epidemiology #AntigenProcessingAndPresentation #DesignProductionAndDevelopmentOfVaccines #VaccineVectors #CellularAndMolecularImmuneResponses #BreakthroughsInImmunotherapeutics #VaccineSafety #PeertechzPublications #EfficacyAndClinicalTrials #ImmunityToInfection #Immunomodulation #CaseReports #ClassicalImmunology #ClinicalImmunology #ComputationalImmunology #DiagnosticImmunology #EvolutionaryImmunology #Immunotherapy #SystemsImmunology #CancerImmunology #TesticularImmunology
To view or add a comment, sign in
-
https://lnkd.in/g2Kvd9Rz Article title: Alopecia areata Author(s): Chieh Chen* Journal: Journal of Vaccines and Immunology Journal ISSN: 2640-7590 Abstract: Alopecia areata, which is a condition with characteristic regional hair loss on the top of the head, is quite common in outpatient departments and clinics. The hair loss is rather rapid during the acute phase and the development into a severe form of alopecia may be related to the younger onset, along with nail changes, family history of atopic dermatitis, allergic rhinitis, asthmatic bronchitis, etc., or other autoimmune diseases. Physically, a large area of hair loss can be observed, as well as other typical features, including broken hair roots and exclamation mark hairs. The classic histopathological sign is the infiltration of lymphocytes around the hair follicles. Moreover, alopecia is not limited to the scalp, and hairs on any part of the body are subjected to the effect of this disease. #Alopeciaareata #Canitiessubita #Queenmarysyndrome #ImmunologyMechanisms #AnimalModelsForImmunologicDiseases #ViralImmunology #Peertechz #Immunopathogenesis #VaccineDevelopmentAndEfficacyEvaluation #ImmuneResponsesToVaccines #VaccineTechnology #VaccineVectors #AdjuvantsAndImmunomodulators #ProphylacticVaccines #TherapeuticVaccines #AIDSVaccines #GeneVaccines #VaccinesInBioterrorism #RegulatoryAffairs #CommercialUtilization #Policy #Safety #Epidemiology #AntigenProcessingAndPresentation #DesignProductionAndDevelopmentOfVaccines #VaccineVectors #CellularAndMolecularImmuneResponses #BreakthroughsInImmunotherapeutics #VaccineSafety #PeertechzPublications #EfficacyAndClinicalTrials #ImmunityToInfection #Immunomodulation #CaseReports #ClassicalImmunology #ClinicalImmunology #ComputationalImmunology #DiagnosticImmunology #EvolutionaryImmunology #Immunotherapy #SystemsImmunology #CancerImmunology #TesticularImmunology
To view or add a comment, sign in
-
https://lnkd.in/gxBqdMYw Article title: Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion Associated with Rhinovirus Infection Author(s): N Zafer Kurugol, Sule Gokce, Cenk Eraslan, E Ulas Saz, Sirmen Kizilcan and M Ozgur Cogullu Journal: Journal of Vaccines and Immunology Journal ISSN: 2640-7590 Abstract: We report a 7-year-old patient with mild encephalopathy with a reversible splenial lesion (MERS) presenting with recurrent delirious behavior, hallucinations and seizures following common cold. Cranial MRI showed high signal intensity in the splenium of the corpus callosum. Rhinovirus was detected in the nasopharyngeal swab by multiplex PCR. Other respiratory viruses were not detected. Microbiologic tests for Epstein-Barr virus, herpes simplex virus, varicella-zoster virus, cytomegalovirus, measles, mumps, rubella and Mycoplasma pneumoniae were also negative. This is the first reported case of MERS associated with rhinovirus infection. #MildEncephalitis #Encephalopathy #ReversibleSplenialLesion #Rhinovirus #Steroid #ImmunologyMechanisms #AnimalModelsForImmunologicDiseases #ViralImmunology #Peertechz #Immunopathogenesis #VaccineDevelopmentAndEfficacyEvaluation #ImmuneResponsesToVaccines #VaccineTechnology #VaccineVectors #AdjuvantsAndImmunomodulators #ProphylacticVaccines #TherapeuticVaccines #AIDSVaccines #GeneVaccines #VaccinesInBioterrorism #RegulatoryAffairs #CommercialUtilization #Policy #Safety #Epidemiology #AntigenProcessingAndPresentation #DesignProductionAndDevelopmentOfVaccines #VaccineVectors #CellularAndMolecularImmuneResponses #BreakthroughsInImmunotherapeutics #VaccineSafety #PeertechzPublications #EfficacyAndClinicalTrials #ImmunityToInfection #Immunomodulation #CaseReports #ClassicalImmunology #ClinicalImmunology #ComputationalImmunology #DiagnosticImmunology #EvolutionaryImmunology #Immunotherapy #SystemsImmunology #CancerImmunology #TesticularImmunology
To view or add a comment, sign in
-
https://lnkd.in/gnVWY9mv Article title: Several peripheral blood cells and the infection of sever acute respiratory syndrome coronavirus 2 Author(s): Jianwei Zhou*, Cui Kong and Yin Sun Journal: Journal of Vaccines and Immunology Journal ISSN: 2640-7590 Abstract: Blood routine is a common laboratory index in clinic, and used as an auxiliary item for diagnosing many diseases. Currently, sever acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection has been a pandemic concern which severely threatens human health [1]. Many clinicians and researchers around the world are focusing on the study of such an infection or the coronavirus disease (COVID-19) caused by the pathogen. Among the studies, the changes of Peripheral Blood Cells (PBC) belong to blood routine are generally investigated [2,3]. In the present report, we will overview the studies on the several PBC of the patients with SARS-Cov-2 infection. #Coronavirus #Respiratorysyndrome #ImmunologyMechanisms #AnimalModelsForImmunologicDiseases #ViralImmunology #Peertechz #Immunopathogenesis #VaccineDevelopmentAndEfficacyEvaluation #ImmuneResponsesToVaccines #VaccineTechnology #VaccineVectors #AdjuvantsAndImmunomodulators #ProphylacticVaccines #TherapeuticVaccines #AIDSVaccines #GeneVaccines #VaccinesInBioterrorism #RegulatoryAffairs #CommercialUtilization #Policy #Safety #Epidemiology #AntigenProcessingAndPresentation #DesignProductionAndDevelopmentOfVaccines #VaccineVectors #CellularAndMolecularImmuneResponses #BreakthroughsInImmunotherapeutics #VaccineSafety #PeertechzPublications #EfficacyAndClinicalTrials #ImmunityToInfection #Immunomodulation #CaseReports #ClassicalImmunology #ClinicalImmunology #ComputationalImmunology #DiagnosticImmunology #EvolutionaryImmunology #Immunotherapy #SystemsImmunology #CancerImmunology #TesticularImmunology
To view or add a comment, sign in
-
https://lnkd.in/g6DKEwdv Article title: Adult-onset Still’s disease complicated with macrophage activation syndrome: A case report Author(s): MNSK Perera1* and A Gunapala Journal: Journal of Vaccines and Immunology Journal ISSN: 2640-7590 Abstract: Adult-onset Still’s disease is a rare systemic disease while macrophage activation syndrome is a fulminant complication of Still’s disease. As mortality is high in macrophage activation syndrome, prompt diagnosis is crucial to commence definitive management. Adult-onset Still’s disease is a rare systemic disease while macrophage activation syndrome is a fulminant complication of Still’s disease. As mortality is high in macrophage activation syndrome, prompt diagnosis is crucial to commence definitive management. Macrophage activation syndrome is a complication of adult-onset Still’s disease. When first-line immunosuppressives fail, second-line medications including biologic therapy can be considered with good results. #Adult-onsetStill’sdisease #Macrophageactivationsyndrome #Tocilizumab #ImmunologyMechanisms #AnimalModelsForImmunologicDiseases #ViralImmunology #Peertechz #Immunopathogenesis #VaccineDevelopmentAndEfficacyEvaluation #ImmuneResponsesToVaccines #VaccineTechnology #VaccineVectors #AdjuvantsAndImmunomodulators #ProphylacticVaccines #TherapeuticVaccines #AIDSVaccines #GeneVaccines #VaccinesInBioterrorism #RegulatoryAffairs #CommercialUtilization #Policy #Safety #Epidemiology #AntigenProcessingAndPresentation #DesignProductionAndDevelopmentOfVaccines #VaccineVectors #CellularAndMolecularImmuneResponses #BreakthroughsInImmunotherapeutics #VaccineSafety #PeertechzPublications #EfficacyAndClinicalTrials #ImmunityToInfection #Immunomodulation #CaseReports #ClassicalImmunology #ClinicalImmunology #ComputationalImmunology #DiagnosticImmunology #EvolutionaryImmunology #Immunotherapy #SystemsImmunology #CancerImmunology #TesticularImmunology
To view or add a comment, sign in
-
Researchers at the Arizona State University Biodesign Institute have made an impressive leap in disease detection, with a novel screening method that can look at hundreds of disease markers and evaluate thousands of samples simultaneously, delivering most results in 24 hours. Unlike conventional blood tests, the new platform, called Multiplexed In-Solution Protein Array (MISPA), looks at many disease factors at once. Scientists put the new method to the test in two sets of sampling experiments across the ASU community, described in the current issue of the journal Microbiology Spectrum. MISPA demonstrates an accuracy comparable with, or better than, existing commercial tests while displaying superior versatility, stability and testing capacity compared with conventional methods. The adaptability and scalability of the technique make it well-suited for diverse applications, ranging from tracking infectious disease outbreaks to understanding the immune landscape of populations and gauging responses to immunization efforts. The MISPA platform uses full-length, folded proteins known as antigens, each tagged with a unique #DNA strand. The antigens detect and bind to antibodies that are produced by the immune system in response to infection.The technique promises to make individual diagnosis and population-wide monitoring of disease faster, more accurate and more comprehensive. “There are number of medical scenarios where doctors need to test for multiple possible disease exposures to deliver the best care,” according to corresponding author Joshua LaBaer. “One example would be pregnancy. Currently, this requires drawing multiple tubes of blood and conducting many separate tests. So we were looking to create a reliable and reproducible test that could evaluate all those exposures at once and only require a drop of blood. This technology will allow us to get there.” #ASU #ASUBiodesign #ASUResearch
To view or add a comment, sign in
-
Clinical Biochemist | Dual Master's in Digital Health and Public Health Management | COVID-19 Expert | Leader in Clinical Diagnostics | Published Scientist.
This study examines the natural progression of post-COVID symptoms in adults and children, shedding light on the prevalence, duration, and associated risk factors. Analyzing data from over 6500 COVID-19 survivors, the research reveals that a significant proportion experience lasting symptoms, with prevalence decreasing over time. Risk factors for persistent symptoms include age, gender, comorbidities like diabetes mellitus, and infection during the Delta period. Surprisingly, vaccination history does not show a significant association with post-COVID symptoms. These findings underscore the importance of understanding the long-term effects of COVID-19 and implementing appropriate support measures for affected individuals. #COVID19 #PostCOVIDSymptoms #LongCOVID #HealthResearch #Epidemiology #PublicHealth #Survivorship #Vaccination #DeltaVariant #RiskFactors #MedicalScience #HealthcarePolicy
Natural course of post-COVID symptoms in adults and children - Scientific Reports
nature.com
To view or add a comment, sign in
-
On the occasion of World Hepatitis Day, we are sharing this excellent e-module developed by the ISAC Viral Infections Working Group and produced by our colleagues at Page Medical. Hepatitis C Virus: Tackling this infection with Direct Acting Antivirals The course is aimed at early career healthcare professionals interested in learning more about HCV, including hepatologists and other prescribing clinicians, medical microbiologists, virologists, nurses and lab technicians. Course Aims The course is aimed at early career healthcare professionals interested in learning more about HCV, including hepatologists and other prescribing clinicians, medical microbiologists, virologists, nurses and lab technicians. You will start by learning about HCV including the structure of the virus, the epidemiology and clinical presentation. You will then explore HCV coinfection before moving on to learn about treatment methods and reasons why treatment may fail, such as antimicrobial resistance. Lastly, you will learn about occult HCV and the risks this type of infection poses to patients. You will also have the opportunity to follow and discuss two case studies as the course progresses. By the end of this course you will be able to... * Identify Hepatitis C Virus (HCV) structure * Explain HCV coinfection * Classify Direct Acting Antivirals (DAAs) for HCV * Explain causes of HCV treatment failure * Discuss mechanisms of HCV resistance to DAAs * Define occult HCV * Discuss pathophysiology of occult HCV * Explain diagnosis and importance of occult HCV Sign up for free ⬇️ https://lnkd.in/eSBhXgid #WorldHepatitisDay #Hepatitis #viralinfections #HepC #virology #infection #infectiousdisease #antivirals #globalhealth #publichealth #healthcare #heptology #microbiology Page Medical Hannah Stewart The World Hepatitis Alliance World Hepatitis Alliance
To view or add a comment, sign in
-
''Jonathan Osagie, ''Quantum Analytics NG Covid 19 Situation Report on Nigeria IN FOCUS: COVID-19 Research in Nigeria Research is a key public health tool in the effective detection, prevention and control of diseases including COVID-19. As part of Nigeria’s response to the COVID-19 pandemic, the Nigeria Centre for Disease Control (NCDC), Federal Ministry of Health, Tertiary Education Trust Fund (TET Fund), and the National Universities Commission (NUC) formed the Nigeria COVID-19 Research Coalition (NCRC) with the aim of strengthening scientific knowledge on COVID-19 in Nigeria and globally. Recently on 4th April 2022, the NCRC held a research colloquium with the theme “Two Years On: Gains, Losses and Lessons in Nigeria’s COVID-19 Research” to showcase the work of scientists and identify gaps in COVID-19 research and other health emergencies. Researchers from across 20 government and non-governmental institutions presented findings under the sub-themes: COVID-19 Diagnostics, Transmission and Epidemiology; Health Systems Research; Social and Behavioral Research; Vaccines, Therapeutics and Clinical Management; Syndemics in COVID-19; Infection Prevention and Control; and One Health Approach. The wealth of data generated since April 2020 was applauded and the need for improvement in vaccine studies and more research on subpopulations including children, pregnant women and the immunocompromised was highlighted at the event. There have been significant investment for COVID-19 research by the Federal Government of Nigeria through the TET Fund’s National Research Grant, and the Central Bank of Nigeria’s Healthcare Sector Research Fund and Development Intervention Scheme (HSRDIS) among others. We are grateful for this strong political commitment and urge the private sector to invest in research for informed decision making and effective action against COVID-19. Research for COVID-19 remains a multi-disciplinary effort, requiring multi-institutional collaboration and integration of the human, animal, and environmental sectors to guide policy and programmes to respond to the pandemic. NCDC continues to incorporate the government, research institutions, industry and health consumers in the production and dissemination of data on COVID-19 to protect the health of Nigerians. Insights Total Active cases – 27 Total Confirmed Cases – 255515 Total Death – 3142 Total Recoveries – 253380 Total State – 37 Total Citizens -4941516 Many thanks to Quantum Analytics NG, my facilitators Jonathan Osagie, Christian Okwara for the opportunity given me to share my knowledge and experience on the internship program
To view or add a comment, sign in
59 followers